Molnupiravir represents a significant development in the battle against COVID-19, functioning as an oral antiviral agent. Early designed to combat viruses, its unique mechanism of action – introducing errors into the SARS-CoV-2's genetic code get more info – has demonstrated efficacy in reducing the risk of severe illness and hospitalization in